ScholarIQanswers from OpenAlex

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

PaperCitations, authors & open-access status

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes have?

ScholarIQcitation count

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes has 2,122 citations in the OpenAlex counts ScholarIQ stores.

When was The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes published?

ScholarIQyear

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes has 2007 year in the ScholarIQ index.

What is the open-access status of The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes?

ScholarIQoa status

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes has bronze oa status in the ScholarIQ index.

What is the DOI of The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes?

ScholarIQdoi

The DOI for The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes is on the source record.

What is the PMID of The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes?

ScholarIQpmid

The PMID for The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes is on the source record.

What is the OpenAlex record for The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes?

ScholarIQopenalex

The OpenAlex for The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial